Linezolid 600 mg

DRUG5 trials

Conditions

Bacterial InfectionsGram-Positive Bacterial InfectionsSkin Diseases, BacterialStaphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)Thrombocytopenia; DrugsTuberculosisTuberculosis, Multidrug-ResistantTuberculosis, Pulmonary

Phase 1

A Study To Assess The Effect Of Linezolid On QTc Interval

CompletedNCT00795145

PfizerBacterial Infections

Start: 2008-12-31End: 2009-03-31Updated: 2010-06-22

Phase 2

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

CompletedNCT03747497

MicuRxSkin Diseases, Bacterial, Gram-Positive Bacterial Infections

Start: 2018-11-15End: 2019-03-26Updated: 2022-11-08

Linezolid Dosing Strategies in Drug-Resistant TB

CompletedNCT05007821

National Institute of Allergy and Infectious Diseases (NIAID)Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary

Start: 2022-09-27End: 2026-01-13Updated: 2026-05-01

Unknown Phase

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT

NCT05944445

Helwan UniversityThrombocytopenia; Drugs

Start: 2023-07-13End: 2024-08-31Target: 310Updated: 2023-07-17

Linezolid Plus Standard of Care

RecruitingNCT06958835

University Hospital, Basel, SwitzerlandStaphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)

Start: 2025-10-06End: 2028-10-01Target: 606Updated: 2026-07-13

Related Papers

Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trial.